bisaramil has been researched along with flecainide in 4 studies
Studies (bisaramil) | Trials (bisaramil) | Recent Studies (post-2010) (bisaramil) | Studies (flecainide) | Trials (flecainide) | Recent Studies (post-2010) (flecainide) |
---|---|---|---|---|---|
22 | 1 | 1 | 1,881 | 229 | 490 |
Protein | Taxonomy | bisaramil (IC50) | flecainide (IC50) |
---|---|---|---|
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.8905 | |
Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Sugimoto, T; Yamashita, T | 1 |
Haruno, A; Hashimoto, K | 1 |
Haruno, A; Hashimoto, K; Sugiyama, A | 1 |
4 other study(ies) available for bisaramil and flecainide
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Medical management of arrhythmias; newer antiarrhythmic drugs].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Chlorobenzenes; Flecainide; Humans; Membrane Potentials; Moricizine; Piperidines; Propylamines; Pyridines; Sodium Channels | 1991 |
Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Chlorobenzenes; Digitalis Glycosides; Disease Models, Animal; Disopyramide; Dogs; Epinephrine; Female; Flecainide; Injections, Intra-Arterial; Lidocaine; Male; Ouabain; Verapamil | 1995 |
Chronotropic, inotropic, dromotropic and coronary vasodilator effects of bisaramil, a new class I antiarrhythmic drug, assessed using canine isolated, blood-perfused heart preparations.
Topics: Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Blood Flow Velocity; Bridged Bicyclo Compounds, Heterocyclic; Chlorobenzenes; Coronary Vessels; Disopyramide; Dogs; Female; Flecainide; Heart; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Reperfusion; Sinoatrial Node; Vasodilation | 1999 |